Skip to main content

ACR/AAHKS Guidelines on Perioperative Management

Jun 21, 2017 2:07 pm

By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.

Rheumatologists’ Comments

Comments

Robert Kimelheim

| Jun 26, 2017 9:49 pm

This may be a bizarre question, but, what exactly is meant by holding a biolgic for one dosing schedule? e.g. If someone receives infliximab Q8 weeks do you give at the end of the 8 weeks or wait an additional 8 weeks then administer - in either scenario, what if that same drug is administered Q4-6 weeks?

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×